Results 211 to 220 of about 1,090,190 (299)

From understanding to agreement: The current state of informed consent in Nigerian endoscopic practice. [PDF]

World J Methodol
Okonkwo KC, Davwar PM, Musa Y, Bojuwoye MO, Onyia CP, Egboh SC, Chukwurah SN, Obasi E, Asaolu OI, Adiri WN, Okeke UF, Dankiri NA, Udigwe CF.   +12 more
europepmc   +1 more source

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

British Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay, Amandine Manon, Hunter Stephens, S. Y. Amy Cheung, Bart de Keizer, Erik T. te Beek   +5 more
wiley   +1 more source

The widening partisan gap in legislative support for civil rights in the United States. [PDF]

Nat Commun
Jackson JC, Liu Y, Kteily N.
europepmc   +1 more source

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

British Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Correction: Role perceptions and willingness to engage among older adults in the context of active aging: a qualitative study in Dalian, China. [PDF]

Front Public Health
Lou X, Leng J, Guan J, Xu L, Zhou X.
europepmc   +1 more source

Beyond the label: Rethinking off‐label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapy

British Journal of Clinical Pharmacology, EarlyView.
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden, Miriam G. Mooij, Matthijs de Hoog, Saskia N. de Wildt   +3 more
wiley   +1 more source

Mapping the Public Health Landscape in Greece: Governance, Stakeholders, Data Systems, and Policy Frameworks. [PDF]

Int J Environ Res Public Health
Triantafyllou C, Ntikoudi A, Papachristou A, Psiakis V, Fonseca VR, Breda J.   +5 more
europepmc   +1 more source

Zuranolone: A case study in (regulatory) rush to judgement?

British Journal of Clinical Pharmacology, EarlyView.
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove, Milutin Kostic, Barbara Mintzes, Gianna D'Ambrozio, Allen Shaughnessy   +4 more
wiley   +1 more source

State of Digital Health in 32 Countries of the WHO African Region: A Multi-Country Maturity Assessment with Short-Term Longitudinal Comparisons Across Leadership, Policy, and Health Systems Domains (2023 - 2025). [PDF]

J Healthc Leadersh
Ahmed MM, Ali HO, Othman ZK.
europepmc   +1 more source

Decoding RNA regulation: Challenges and opportunities for RNA‐based therapies in Europe

British Journal of Clinical Pharmacology, EarlyView.
Abstract RNA‐based medicinal products represent a promising frontier in personalised medicine, offering sequence‐specific disease targeting at various molecular levels, yet their clinical translation in the European Union (EU) may be hindered by regulatory uncertainty around definitions and evidence requirements; this study therefore aims to identify ...
Olivia C. Lewis, Christine Leopold, Joyce M. Hoek, Raymond M. Schiffelers, Marie L. De Bruin   +4 more
wiley   +1 more source